FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro

doi 10.1101/2020.03.25.008482
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy